Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

06 March 2025

Op-ed: Trump aid shock underscores need for more made-in-Africa medicine

For Devex, the Access to Medicine Foundation’s CEO Jayasree K. Iyer highlights how US aid cuts will impact Africa, stressing the need to expand local manufacturing, streamline regulation and reduce reliance on imports.

Direct links

Read the full op-ed

Amid geopolitical shifts and rising healthcare nationalism, including US President Donald Trump’s cuts to the foreign aid budget, Africa now faces critical shortages of essential medicines and vaccines. In her Dexex article, Jayasree K. Iyer writes that to sustain access, African countries must reduce reliance on external support.

As Iyer points out, with the majority (80%) of its medicines imported, the continent has only about 375 drugmakers, most of them in North Africa, while India and China have approximately 10,000 and 5,000 manufacturers, respectively. This highlights Africa’s insufficient local manufacturing capacity, leaving more than 1.5 billion people chronically susceptible to shortages of essential healthcare products.

Iyer discusses opportunities to bolster local manufacturing, and in turn, reduce reliance on foreign aid. Some African manufacturers already produce essential medicines and are even expanding into vaccines and complex medicines such as biologics. However, without government incentives, such as tax breaks and offtake agreements to help domestic manufacturers compete in the global market, this avenue will present significant challenges.


Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the media

Read other op-eds by Jayasree K. Iyer
Media

Op-ed: Climate displacement is also a health crisis

28 January 2025
Media

Op-ed: How equitable access to medicines can drive sustainable returns for investors

19 November 2024
Media

Op-ed: Obesity drugs pose a big challenge for health care equity

07 June 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved